OBJECTIVE
Methylxanthines and doxapram are currently used to treat apnea of prematurity but are not fully effective and often present undesirable side effects. The present study examines whether exposure to an odor known to modulate the infant's respiratory rate could reduce the frequency of apneic spells.
METHOD
Fourteen preterm newborns born at 24 to 28 gestational weeks presenting recurren...
